TopFunds

The Clorox Company

NYSE: CLX

Stock price

87.09 USD

(+0%) TODAY

Household & Personal Products
Financials

all figures in US$ Millions except per share data

Sections:

Periods:

View:

Format:

Actual
10 year cagr
Help
Where available up to 10y CAGR shown for absolute numbers 10y Average marked A shown for relative numbers such as margins
Fiscal
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Average (A)
Fiscal period end dates
Expand all rows
01Earnings per share
Help
Earnings per share = Net Income / Number of Shares Outstanding
4.9
5.3
6.3
6.3
7.4
5.6
3.7
1.2
2.3
6.5
4.8
(0.2)%
02Free cash flow per share
4.6
4.8
5.9
6.1
10.1
7.4
4.3
7.5
3.9
6.1
3.3
(3.2)%
03Dividends per share
3.1
3.2
3.5
3.8
4.2
4.4
4.6
4.7
4.8
4.9
5
4.9%
04Dividends payout, %
61.4%
58.8%
54.7%
59.8%
56.8%
78.6%
1.2%
3.9%
2.1%
74.3%
1%
(33.6)%
PROFIT AND LOSS STATEMENT
05Revenue
5,761
5,973
6,124
6,214
6,721
7,341
7,107
7,389
7,093
7,104
6,720
1.6%
06% Change
-
-
-
-
-
-
-
-
-
-
-
1.6%
07Cost of revenue
(3,163)
(3,302)
(3,449)
(3,486)
(3,658)
(4,142)
(4,562)
(4,481)
(4,045)
(3,891)
(3,876)
2.1%
08Gross profit
2,598
2,671
2,675
2,728
3,063
3,199
2,545
2,908
3,048
3,213
2,844
0.9%
09% Margin
45.1%
44.7%
43.7%
43.9%
45.6%
43.6%
35.8%
39.4%
43%
45.2%
42.3%
42.9% A
10Operating expenses
(1,542)
(1,554)
(1,550)
(1,621)
(1,802)
(1,974)
(1,826)
(2,085)
(2,325)
(2,036)
(1,182)
(2.6)%
11% of Revenue
(26.8)%
(26)%
(25.3)%
(26.1)%
(26.8)%
(26.9)%
(25.7)%
(28.2)%
(32.8)%
(28.7)%
(17.6)%
(26.4)% A
12Operating Income
1,056
1,117
1,125
1,107
1,261
1,225
719
823
723
1,177
1,662
4.6%
13Income tax expense
(335)
(330)
(231)
(204)
(246)
(181)
(136)
(77)
(106)
(254)
(190)
(5.5)%
14Net Income
648
701
823
820
939
710
462
149
280
810
587
(1)%
15% Margin
11.3%
11.7%
13.4%
13.2%
14%
9.7%
6.5%
2%
4%
11.4%
8.7%
9.6% A
16Shares Outstanding
131.7
131.6
131.6
129.8
127.7
127.3
123.9
124.2
124.8
124.3
122.1
(0.8)%
17EPS Basic
5
5.4
6.4
6.4
7.5
5.7
3.8
1.2
2.3
6.6
4.8
(0.4)%
18EPS Diluted
4.9
5.3
6.3
6.3
7.4
5.6
3.7
1.2
2.3
6.5
4.8
(0.2)%
19EBITDA
1,236
1,284
1,305
1,301
1,464
1,210
937
564
723
1,385
1,168
(0.6)%
% Margin
21.5%
21.5%
21.3%
20.9%
21.8%
16.5%
13.2%
7.6%
10.2%
19.5%
17.4%
17.4% A
20Net Interest Income (expense)
(83)
(84)
(79)
(94)
(97)
(94)
(101)
(74)
(67)
(79)
(122)
3.9%
21Net Debt / EBITDA
1.5
1.4
1.8
2
1.5
2.4
3.1
4.5
3.7
2
4.6
2.6 A
BALANCE SHEET
ASSETS
Current Assets
22Cash & equivalents
401
418
131
111
871
319
183
367
202
167
143
(9.8)%
23Short-term investments
-
-
-
-
-
-
-
-
-
-
-
-
24Accounts receivable
569
565
600
631
648
604
681
688
695
821
791
3.4%
25Other current assets
72
72
74
51
47
154
106
77
88
97
113
4.6%
26Inventory
443
459
506
512
454
752
755
696
637
523
777
5.8%
27Total Current Assets
1,485
1,514
1,311
1,305
2,020
1,829
1,725
1,828
1,622
1,608
1,824
2.1%
Non-Current Assets
28Net property, plant & equipment
906
931
996
1,034
1,394
1,634
1,676
1,691
1,675
1,600
1,913
7.8%
29Long-term investments
-
-
-
-
-
-
-
-
-
-
-
-
30Other non-current assets
2,127
2,128
2,753
2,777
2,799
2,871
2,757
2,426
2,454
2,353
4,057
6.7%
31Total Non-Current Assets
3,033
3,059
3,749
3,811
4,193
4,505
4,433
4,117
4,129
3,953
5,970
7%
Total Assets
4,518
4,573
5,060
5,116
6,213
6,334
6,158
5,945
5,751
5,561
7,794
5.6%
LIABILITIES
Current Liabilities
32Accounts payable
490
501
507
507
575
930
960
1,021
950
838
1,600
12.6%
33Short-term debt
523
804
199
396
64
381
315
137
88
91
1,173
8.4%
34Other current liabilities
545
504
494
537
779
745
509
759
536
990
-
-
35Total Current Liabilities
1,558
1,809
1,200
1,440
1,418
2,056
1,784
1,917
1,574
1,919
2,773
5.9%
Non-Current Liabilities
36Long-term debt
1,789
1,391
2,284
2,287
3,058
2,785
2,788
2,787
2,815
2,789
4,347
9.3%
37Other non-current liabilities
874
831
850
830
829
901
857
853
870
371
422
(7)%
38Total Non-Current Liabilities
2,663
2,222
3,134
3,117
3,887
3,686
3,645
3,640
3,685
3,160
4,769
6%
39Total Liabilities
4,221
4,031
4,334
4,557
5,305
5,742
5,429
5,557
5,259
5,079
7,542
6%
SHAREHOLDERS` EQUITY
40Common stock
159
159
159
159
159
131
131
131
131
131
131
(1.9)%
41Retained earnings / (deficit)
2,163
2,440
2,797
3,150
3,567
1,036
1,048
583
250
432
386
(15.8)%
42Accumulated other comprehensive income / (loss)
(570)
(543)
(547)
(602)
(640)
(546)
(479)
(493)
(155)
(157)
(157)
(12.1)%
43Noncontrolling interests
-
-
-
-
-
181
173
168
164
161
162
-
44Total shareholders' equity
297
542
726
559
908
592
729
388
492
482
252
(1.6)%
45Total Liabilities and shareholders' Equity
4,518
4,573
5,060
5,116
6,213
6,334
6,158
5,945
5,751
5,561
7,794
5.6%
46Total Debt
2,312
2,195
2,483
2,683
3,122
3,166
3,103
2,924
2,903
2,880
5,520
9.1%
47Net Debt
1,911
1,777
2,352
2,572
2,251
2,847
2,920
2,557
2,701
2,713
5,377
10.9%
CASH FLOW STATEMENT
CASH FLOWS FROM OPERATING ACTIVITIES
48Net income (loss)
648
701
823
820
939
710
462
149
280
810
587
(1)%
49Depreciation & amortization
165
163
166
180
180
211
224
236
235
219
247
4.1%
50Share-based compensation expense
45
51
53
43
50
50
52
73
74
81
48
0.7%
51Changes in working capital and other assets
(80)
(47)
(68)
(51)
377
305
48
700
106
(129)
(270)
12.9%
52Net cash flows from operating activities
778
868
974
992
1,546
1,276
786
1,158
695
981
612
(2.4)%
CASH FLOWS FROM INVESTING ACTIVITIES
53Purchases of property, plant and equipment
(172)
(231)
(194)
(206)
(254)
(331)
(251)
(228)
(212)
(220)
(207)
1.9%
54Purchases of investments / marketable securities
-
-
-
-
-
-
-
-
-
-
-
-
55Proceeds from maturities of marketable securities
-
-
-
-
-
-
-
-
-
-
-
-
56Other investing activities
(258)
26
(665)
10
2
(121)
22
5
37
126
(2,094)
23.3%
57Net cash flows from investing activities
(430)
(205)
(859)
(196)
(252)
(452)
(229)
(223)
(175)
(94)
(2,301)
18.3%
CASH FLOWS FROM FINANCING ACTIVITIES
58Issuance (repurchases) of common stock, net
(44)
(108)
(226)
(514)
(86)
(802)
(20)
33
1
(306)
(279)
20.3%
59Dividends paid, net
(398)
(412)
(450)
(490)
(533)
(558)
(571)
(583)
(595)
(602)
(602)
4.2%
60Debt issuance (repayments), net
126
(125)
277
189
96
-
(83)
(188)
(45)
-
2,565
35.2%
61Other financing activities
-
-
-
-
-
(31)
(15)
(15)
(16)
(16)
(16)
-
62Net cash flows from financing activities
(316)
(645)
(399)
(815)
(523)
(1,391)
(689)
(753)
(655)
(924)
1,668
-
63Increase (decrease) in cash and cash equivalents
19
17
(287)
(21)
766
(555)
(138)
184
(161)
(35)
(23)
-
64Cash and equivalents, ending balance
401
418
131
113
879
324
186
367
207
167
147
(9.6)%
65Free Cash Flow to the Firm (FCFF)
Help
Free Cash Flow to the Firm = Cash Flows from Operating Activities - Capital Expenditures
606
637
780
786
1,292
945
535
930
483
761
405
(4)%

Annual Reports, Presentations And IR Contacts

Go to the website
Annual report links (10K)
20262025202420232022202120202019201820172016

The Clorox Company (CLX) financial statements and performance

Explore The Clorox Company (CLX) annual and quarterly financial statements, including revenue, operating income, net income, cash flow, assets, liabilities, and per-share metrics.

Compare reporting periods and financial trends to evaluate profitability, balance-sheet strength, cash generation, and long-term business performance.